[Prokinetic drugs in digestive disorders].
In this paper the authors review the main prokinetic drugs analyzing their pharmacological properties, therapeutic indications and adverse effects. In addition, some more recently introduced substances are taken into consideration which, although they were not initially used for digestive tract dyskinesias, can nevertheless be used in certain conditions. From this point of view, calcium blocking agents employed in spastic conditions of the esophagus and the new antiserotoninergic drugs for treatment of anticancer chemotherapy-induced vomiting are of particular interest.
Carella
G
G
Istituto di Patologia Speciale Medica, Università Cattolica del S. Cuore di Roma.
Marra
L
L
D000970:Antineoplastic Agents / Q000009:adverse effects; D020117:Cisapride; D004294:Domperidone / Q000627:therapeutic use*; D015154:Esophageal Motility Disorders / Q000188:drug therapy; D005764:Gastroesophageal Reflux / Q000188:drug therapy; D005769:Gastrointestinal Motility / Q000187:drug effects*; D006801:Humans; D008787:Metoclopramide / Q000627:therapeutic use*; D010880:Piperidines / Q000627:therapeutic use*; D012702:Serotonin Antagonists / Q000627:therapeutic use; D014839:Vomiting / Q000139:chemically induced / Q000188:drug therapy / Q000517:prevention & control
D000970:Antineoplastic Agents; D010880:Piperidines; D012702:Serotonin Antagonists; D004294:Domperidone; D008787:Metoclopramide; D020117:Cisapride
I procinetici in patologia digestiva.